Encapsulation is one of the most frequently requested technologies in cosmetic development and one of the most frequently misunderstood. A brand asks for encapsulated vitamin C, encapsulated retinol or encapsulated fragrance, and the assumption is that encapsulation delivers something a conventional formula cannot.
Sometimes it does. Encapsulation can protect an unstable active from oxidation, separate two ingredients that would otherwise react, convert a liquid into a free-flowing powder, or release a fragrance at a defined moment. It does not automatically improve performance, and it does not automatically justify a claim.
This guide explains the main encapsulation technologies, what each is actually good for, the processing and compatibility constraints they impose, the claim boundaries, and how encapsulation affects cost and minimum order quantity.
Why delivery systems exist
Four problems motivate almost every encapsulation project, and identifying which one applies is the first step in choosing a technology.
The first is instability. An active that oxidises, hydrolyses or degrades in the presence of water or light can be protected inside a wall material that physically separates it from the rest of the formula until the moment of use. The second is incompatibility: two ingredients that cannot coexist in one phase can be kept apart by encapsulating one of them. The third is controlled release, where the material is designed to release its contents at a defined trigger such as moisture, pH, temperature or mechanical pressure. The fourth is handling form, where a liquid or an oil is converted into a powder so that it can be blended into a solid or a powder product.
The technology follows from the problem. A brand that asks for encapsulation without specifying which of these four it needs is likely to receive a solution for the wrong one, at the wrong cost.
The main encapsulation technologies
Several routes are commercially available, and they differ in wall material, particle size, release mechanism and the cost of the equipment they require.
| Technology | Typical payload | Release trigger | Main constraint |
|---|---|---|---|
| Liposomes and phospholipid vesicles | Water-soluble and some oil-soluble actives | Gradual diffusion and membrane disruption on skin | Physically fragile, sensitive to surfactants and to shear, and difficult to stabilise over a long shelf life |
| Niosomes and non-ionic vesicles | Actives and oils | Diffusion and disruption | Similar fragility to liposomes, with a different compatibility profile |
| Polymeric microcapsules | Fragrance, oils, some actives | Mechanical pressure, diffusion or pH | Wall chemistry determines regulatory acceptability; some wall materials attract scrutiny |
| Cyclodextrin complexes | Fragrance and odour-active molecules | Moisture and temperature | Low payload relative to the carrier mass, so the inclusion level is high |
| Spray-dried powders with a wall material | Oils, botanical extracts, flavours | Dissolution of the wall in water | Large particles relative to the payload, and stability depends on moisture control |
| Softgel capsules | Oils and oil-miscible actives | Physical rupture or dissolution of the shell | Not a dispersion technology; a single-dose format with its own filling constraint |
The distinction between encapsulation inside a formula and a softgel capsule is worth keeping clear. The first is a dispersion of very small particles in a base. The second is a manufactured dosage form in which the shell is the container, and it is discussed separately below.
Liposomes and vesicle systems
Liposomes are microscopic vesicles with an aqueous core enclosed in one or more lipid bilayers. Because the structure has both a water-loving core and an oil-loving shell, it can carry both types of active, which is the source of its appeal.
The technical difficulty is fragility. The bilayer is sensitive to surfactants, which is a serious constraint because surfactants are present in cleansers and in many emulsions that use a high emulsifier level. It is also sensitive to shear, so high-shear homogenisation during manufacture can destroy the structure, and to storage temperature. And the vesicles tend to fuse or leak over time, which means the encapsulation efficiency falls during the shelf life.
The practical consequences for a brief are straightforward. A liposomal system belongs in a low-surfactant, low-shear product such as a serum or a light emulsion, not in a cleanser. The manufacturing process has to be adapted to add the system after the high-shear stage. And the stability study has to include a measure of the encapsulation efficiency or of the active's retention, because a formula can look perfectly stable while the delivery system has quietly collapsed.
Softgel capsules and single-dose formats
A softgel capsule is a sealed shell, usually based on a gelling agent, containing a liquid fill. It is a single-dose format rather than an encapsulation technology in the dispersion sense, and it solves a different set of problems.
Its main advantages are protection and precision. The shell isolates the fill completely from the environment until the capsule is opened or ruptured, which makes it the most effective available protection for an oxidation-sensitive oil. The dose is fixed and consistent, which suits actives whose effective concentration matters. And the format itself has a strong consumer appeal, particularly in facial serum categories where the visual ritual is part of the proposition.
The constraints are equally real. The fill has to be compatible with the shell material and must not migrate through it, which limits the solvent and surfactant content of the fill. The shell chemistry determines the vegan status, since traditional shells are gelatin-based and alternatives based on plant-derived materials are widely available but behave differently. Filling is a specialised process with its own minimum run. And the capsule must be stable enough not to leak at elevated ambient temperature, which is a real constraint for products shipped through warm climates.
Our pink capsule facial serum and hyaluronic acid softgel capsule programmes are examples of the format: the development work centres on the shell composition, the fill compatibility and the stability of the sealed unit rather than on dispersion in a base.
Microencapsulation for fragrance
Fragrance encapsulation is the most commercially mature application, and its purpose is usually controlled release rather than protection. Encapsulated fragrance can be designed to remain intact in the pack and release when the product is rubbed on skin, which produces a burst of scent at the moment of use.
The technology works, and the important consideration is the wall material. Several wall chemistries are available and their regulatory acceptability differs between markets, particularly for products applied to the skin and for products with any ingestion exposure. A brand should ask for the wall material to be identified explicitly and check it against its target markets rather than accepting a generic description.
Two performance limitations are worth knowing. Encapsulated fragrance releases its payload once, so the long-term scent on skin still depends on the free fragrance in the base. And the capsules can settle or cream in a low-viscosity formula, which produces an uneven scent experience across the pack, so suspension aids are usually required.
What encapsulation can and cannot do
Encapsulation can protect, separate, convert a form and delay or trigger a release. Those are engineering achievements and they are verifiable.
What encapsulation does not automatically do is increase the amount of an active that reaches the skin, improve a biological effect, or make a product more effective than a well-formulated conventional alternative. Whether a delivery system improves penetration depends on its size, its surface properties, the state of the skin barrier and the vehicle, and it is a question that has to be answered with data for each specific system rather than assumed from the technology's name.
This distinction matters commercially as well as technically. A brand that markets encapsulation as a performance guarantee is making a claim it may not be able to substantiate, whereas a brand that markets the specific function the system performs, such as protecting an unstable active or releasing fragrance on contact, is describing something it can demonstrate.
Compatibility and processing constraints
Delivery systems impose constraints on the surrounding formula, and these are usually the reason a project takes longer than expected.
Surfactant content is the first constraint for vesicle systems, as described above. Shear is the second, and it affects the point in the process at which the system is added. Temperature is the third: many encapsulated materials are stable only within a moderate range, and adding them to a batch that has not cooled sufficiently can release the payload prematurely or destroy the wall. Electrolytes and pH are the fourth, since some wall materials dissolve or become permeable outside a defined window.
The practical rule is that the delivery system should be selected with the process in mind, not added to an existing process. A manufacturer asked to incorporate a liposomal system into a formula that is homogenised at high shear and filled hot will either refuse or will produce a product in which the system has already failed, and the second outcome is worse because it is invisible.
Cost and minimum order implications
Encapsulated materials are almost always more expensive per kilogram than their conventional equivalents, and the reason is not only the technology. The payload is a fraction of the delivered mass, so the brand buys carrier as well as active, and a cyclodextrin complex in particular can require a large inclusion level to deliver a small amount of fragrance.
Minimum order quantities are affected in two ways. The encapsulated raw material itself carries a supplier minimum, which is often substantial because the material is produced in batches. And where a bespoke encapsulation is developed for the brand, there is a development and validation cost that has to be amortised. A brand with a modest first order is usually better served by a commercially available encapsulated raw material than by a custom encapsulation project, even if the custom route would perform better.
What should a brief contain?
State which of the four problems the brand is trying to solve, the ingredient or the effect that requires encapsulation, the format and process the product will use, the target markets because the wall material has to be acceptable in each, the intended claim, the first order quantity and the target cost.
Two items save development time. State the process conditions the system will have to survive, including the maximum temperature and the shear it will encounter, because those constraints eliminate some technologies immediately. And state whether a commercially available encapsulated raw material is acceptable or whether a bespoke system is required, because the two routes have very different cost and timeline profiles.
Frequently asked questions about encapsulation
Does encapsulation make an active more effective?
Not automatically. It can protect the active and control its release. Whether it improves delivery to the skin depends on the system and the vehicle, and it has to be demonstrated rather than assumed.
Can encapsulated ingredients go into a cleanser?
Usually not if the system is a vesicle type, because surfactants disrupt the structure. Polymeric or powder-based systems are more tolerant, and the specific system should be checked against the surfactant level of the formula.
What wall materials are used?
They range from phospholipids and non-ionic surfactants to various polymers, starches, gums and cyclodextrins. The choice matters for regulatory acceptability as well as for performance, so it should be stated explicitly.
Are capsules the same as encapsulation?
No. A softgel capsule is a single-dose dosage form in which the shell is the container. Encapsulation usually refers to fine particles dispersed within a formula.
Do you supply delivery system documentation?
Yes. Payload, wall material, particle size, recommended inclusion level, processing limits and stability data are provided, together with the documentation needed for the regulatory file.
Next step: name the problem, not the technology
If you are considering an encapsulated active or a capsule format, tell us what the system has to achieve, the format, the process conditions and your markets, and we will propose a technology, an inclusion level and a costed quote. Write to capsulebiotech@163.com, message the right team on WhatsApp: Capsule Series (capsules only) +86 158-7655-5319, Cosmetics Series (serum, hair care, body care, fragrance) +86 158-7655-5319, or use the inquiry form and we will reply within one working day.
Related programmes and guides: pink capsule facial serum, fullerene placenta capsule, and our guides to capsule, ampoule and single-dose formats and why brands switch to capsule formats.